tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Pseudomonas Infections D011552 25 associated lipids
Psoriasis D011565 47 associated lipids
Psychoses, Substance-Induced D011605 7 associated lipids
Pterygium D011625 3 associated lipids
Pulmonary Veno-Occlusive Disease D011668 1 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Rectal Diseases D012002 1 associated lipids
Rectal Fistula D012003 2 associated lipids
Red-Cell Aplasia, Pure D012010 4 associated lipids
Reflex Sympathetic Dystrophy D012019 4 associated lipids
Respiration Disorders D012120 5 associated lipids
Respiratory Insufficiency D012131 10 associated lipids
Respiratory Tract Neoplasms D012142 2 associated lipids
Retinoblastoma D012175 12 associated lipids
Rhabdomyolysis D012206 9 associated lipids
Rheumatoid Nodule D012218 1 associated lipids
Rosacea D012393 13 associated lipids
Rotavirus Infections D012400 1 associated lipids
Rupture D012421 2 associated lipids
Sarcoidosis D012507 13 associated lipids
Sarcoma, Kaposi D012514 6 associated lipids
Osteosarcoma D012516 50 associated lipids
Scalp Dermatoses D012536 11 associated lipids
Sclerosis D012598 5 associated lipids
Dermatitis, Seborrheic D012628 10 associated lipids
Seizures D012640 87 associated lipids
Shock D012769 11 associated lipids
Shock, Septic D012772 11 associated lipids
Sinusitis D012852 9 associated lipids
Skin Diseases, Vesiculobullous D012872 5 associated lipids
Skin Neoplasms D012878 12 associated lipids
Sleep Wake Disorders D012893 7 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Stomach Ulcer D013276 75 associated lipids
Stomatitis D013280 14 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Tachycardia D013610 7 associated lipids
Telangiectasis D013684 2 associated lipids
Testicular Diseases D013733 15 associated lipids
Thinness D013851 11 associated lipids
Thrombocytopenia D013921 15 associated lipids
Thrombophlebitis D013924 6 associated lipids
Thrombosis D013927 49 associated lipids
Thymus Neoplasms D013953 15 associated lipids
Thyroid Diseases D013959 8 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Tinea D014005 5 associated lipids
Tinea Capitis D014006 1 associated lipids
Tongue Diseases D014060 2 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Takada Y et al. Improvement of allograft viability with organs procured from non-heart-beating donors in porcine liver transplantation. 2000 Transplant. Proc. pmid:10715416
Mamane Y et al. Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52. 2000 Immunity pmid:10714679
Egner R et al. The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility. 2000 Mol. Microbiol. pmid:10712705
DuBell WH et al. K(+) currents responsible for repolarization in mouse ventricle and their modulation by FK-506 and rapamycin. 2000 Am. J. Physiol. Heart Circ. Physiol. pmid:10710358
Kitabayashi H et al. FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes. 2000 J. Cardiovasc. Pharmacol. pmid:10710126
Kuriyama S et al. Immunomodulation with FK506 around the time of intravenous re-administration of an adenoviral vector facilitates gene transfer into primed rat liver. 2000 Int. J. Cancer pmid:10709105
Singh N et al. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. 2000 Transplantation pmid:10708096
Lapa e Silva JR et al. Prevention of antigen-induced bronchial hyperreactivity and airway inflammation in sensitized guinea-pigs by tacrolimus. 1999 Mediators Inflamm. pmid:10704085
James JA et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. 2000 J. Clin. Periodontol. pmid:10703661
Bartucci MR Issues in cyclosporine drug substitution: implications for patient management. 1999 J Transpl Coord pmid:10703396
Ulsh PJ et al. New strategies using 'low-dose' mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation. 1999 J Transpl Coord pmid:10703393
Soran A et al. Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients. 1999 J Transpl Coord pmid:10703390
Dumont FJ FK506, an immunosuppressant targeting calcineurin function. 2000 Curr. Med. Chem. pmid:10702636
Rovira P et al. The impact of immunosuppressive drugs on the analysis of T cell activation. 2000 Curr. Med. Chem. pmid:10702633
Migita K et al. FK506 augments glucocorticoid-mediated cyclooxygenase-2 down-regulation in human rheumatoid synovial fibroblasts. 2000 Lab. Invest. pmid:10701683
Williams ST et al. Preliminary analysis of a randomized trial comparing microemulsion cyclosporine and tacrolimus for recipients of renal transplants from non-heart-beating donors. 2000 Transplant. Proc. pmid:10701022
White SA et al. Influence of delayed graft function in renal transplants from cadaveric or non-heart-beating donors. 2000 Transplant. Proc. pmid:10701018
Braun F et al. Living-related versus living-unrelated kidney transplantation using tacrolimus initial immunosuppression. 2000 Transplant. Proc. pmid:10700989
White SA et al. Effect of acute rejection on expression of fibrosis associated genes in renal transplant recipients. 2000 Transplant. Proc. pmid:10700949
Aronowski J et al. Interplay between the gamma isoform of PKC and calcineurin in regulation of vulnerability to focal cerebral ischemia. 2000 J. Cereb. Blood Flow Metab. pmid:10698072
Bader A et al. Primary porcine enterocyte and hepatocyte cultures to study drug oxidation reactions. 2000 Br. J. Pharmacol. pmid:10694240
Davis DL et al. Minor immunophilin binding of tacrolimus and sirolimus metabolites. 2000 Clin. Biochem. pmid:10693980
LaPres JJ et al. ARA9 modifies agonist signaling through an increase in cytosolic aryl hydrocarbon receptor. 2000 J. Biol. Chem. pmid:10692406
Suga Y et al. A case of ichthyosis linearis circumflexa successfully treated with topical tacrolimus. 2000 J. Am. Acad. Dermatol. pmid:10688732
Glynne R et al. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis. 2000 Nature pmid:10688206
Oppenheimer F Steroid withdrawal in renal transplant recipients. 2000 Transplant. Proc. pmid:10686314
Li XC and Strom TB Blocking T-cell costimulation in transplantation: opportunities and challenges. 2000 Transfusion pmid:10685997
Sengoku T et al. FK506 inhibition of histamine release and cytokine production by mast cells and basophils. 2000 Int. J. Immunopharmacol. pmid:10685002
Filler G et al. Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression. 2000 Pediatr. Nephrol. pmid:10684356
Del Poeta M et al. Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. 2000 Antimicrob. Agents Chemother. pmid:10681348
Skuk D and Tremblay JP Progress in myoblast transplantation: a potential treatment of dystrophies. 2000 Feb 1-15 Microsc. Res. Tech. pmid:10679968
Tisdale JF et al. Cyclophosphamide and other new agents for the treatment of severe aplastic anemia. 2000 Semin. Hematol. pmid:10676915
de Mattos AM et al. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. 2000 Am. J. Kidney Dis. pmid:10676738
Misawa A et al. FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation. 2000 Bone Marrow Transplant. pmid:10673708
Sayo Y et al. Transforming growth factor beta induction of insulin gene expression is mediated by pancreatic and duodenal homeobox gene-1 in rat insulinoma cells. 2000 Eur. J. Biochem. pmid:10672004
Hirose R et al. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. 2000 Transplantation pmid:10670644
Jordan ML et al. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. 2000 Transplantation pmid:10670637
Furukawa H et al. Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs. 2000 Transplantation pmid:10670633
Winter C et al. The immunophilin ligand FK506, but not GPI-1046, protects against neuronal death and inhibits c-Jun expression in the substantia nigra pars compacta following transection of the rat medial forebrain bundle. 2000 Neuroscience pmid:10670442
Tyagi MG and Thomas M Enhanced cardiovascular reactivity to desmopressin in water-restricted rats: facilitatory role of immunosuppression. 1999 Methods Find Exp Clin Pharmacol pmid:10669908
Chenhsu RY et al. Renal allograft dysfunction associated with rifampin-tacrolimus interaction. 2000 Ann Pharmacother pmid:10669182
McAlister VC et al. Sirolimus-tacrolimus combination immunosuppression. 2000 Lancet pmid:10665560
Schuppe H et al. Topical tacrolimus for recalcitrant leg ulcer in rheumatoid arthritis. 2000 Rheumatology (Oxford) pmid:10662882
Tamura A et al. Immunosuppressive therapy using FTY720 combined with tacrolimus in rat liver transplantation. 2000 Surgery pmid:10660758
Tamura J et al. [The role of protein kinases and phosphatases in erythroid colony formation of elderly]. 1999 Nihon Ronen Igakkai Zasshi pmid:10655734
Novelli M et al. Oral absorption of tacrolimus in children with intestinal failure due to short or absent small bowel. 1999 Transpl. Int. pmid:10654359
Wu GS et al. Deoxyspergualin delays xenograft rejection in the guinea pig-to-C6-deficient rat heart transplantation model. 1999 Transpl. Int. pmid:10654352
Jain A et al. Conversion to neoral for neurotoxicity after primary adult liver transplantation under tacrolimus. 2000 Transplantation pmid:10653398
Reddy KS et al. Simultaneous kidney-pancreas transplantation without antilymphocyte induction. 2000 Transplantation pmid:10653379
Schrama YC et al. Concealed by veils. 2000 Nephrol. Dial. Transplant. pmid:10648679